Eli Health launches smartphone hormone test Hormometer

The Hormometer by Eli Health transforms smartphones into portable hormone testing devices using saliva samples, with a planned launch at CES 2025.

Breakthrough Technology: Eli Health has developed a first-of-its-kind system that converts smartphones into hormone analysis tools using advanced bioassay and AI technology.

• The FDA-registered system combines microfluidics, bioassay technology, and artificial intelligence to deliver lab-grade hormone test results
• Initial testing capabilities focus on cortisol and progesterone measurements
• The technology represents five years of development work and includes 12 patent-pending innovations

Testing Process and Accuracy: The Hormometer achieves clinical-lab precision through a simple three-step process that takes minutes to complete.

• Users provide a 60-second saliva sample using a specialized cartridge
• The smartphone’s camera and AI algorithms analyze the biofluid sample
• Test results show remarkable accuracy: 97% for cortisol and 94% for progesterone compared to laboratory testing
• The system demonstrates sensitivity up to 1,000,000 times greater than typical at-home testing options

User Experience and Features: The accompanying mobile application provides comprehensive health insights and personalized recommendations.

• Users receive instant test results through their smartphone
• The app tracks hormone trends over time
• Personalized health recommendations help users optimize their wellness based on hormone patterns
• Future development includes planned testing capabilities for testosterone and estradiol

Market Availability and Pricing: The Hormometer’s commercial release is scheduled for early 2025 with a subscription-based model.

• Initial launch targets the United States and Canada markets
• Subscription plans begin at $8 per test with a 12-month commitment
• The pricing structure aims to make hormone testing more accessible compared to traditional lab testing

Future Impact: The development of smartphone-based hormone testing could significantly democratize access to hormone health monitoring, though regulatory approval and real-world performance will be crucial factors in determining the technology’s long-term success and adoption in healthcare settings.